Publications

3 résultats Voir en premier : les plus pertinents | les plus récents
    • Maladies, Statistiques
    • 2011
    • Fiche
    • Français, Anglais

    Cette fiche pays fournit les résultats pour le Luxembourg dans le cadre de l’enquête Eurobaromètre "Sensibilisation des Européens aux maladies rares" publiée en février 2011.

    • Date de parution:
    • Editeur: Commission européenne [European Commission]
    • Maladies, Statistiques
    • 2014
    • Fiche
    • Anglais

    [Maladies non transmissibles: profil du Luxembourg 2014]
    This profile from Luxembourg includes details of what proportion of deaths are due to noncommunicable diseases. Using graphs in a page presentation format, it provides information on prevalence, trends in metabolic risk factors (cholesterol, blood pressure, body mass index and blood sugar) alongside data on the country's capacity to tackle the diseases.
    Noncommunicable diseases are the top cause of death worldwide, killing more than 36 million people in 2008. Cardiovascular diseases were responsible for 48% of these deaths, cancers 21%, chronic respiratory diseases 12%, and diabetes 3%.

    • Date de parution:
    • Editeur: Organisation Mondiale de la Santé (OMS) [World Health Organization (WHO)]
    • Maladies, Politique internationale
    • 2010
    • Ouvrage
    • Anglais

    [Lignes directrices européennes pour l'assurance de la qualité dans le dépistage du cancer colorectal]

    The guidelines on colorectal cancer screening form the third and final set of three cancer screening guidelines on breast and cervical cancer published by the Commission to assist Member States in their screening and early detection programmes.

    Today’s publication provides the first ever set of uniform guidelines on all the steps necessary for effective population based colorectal cancer screening in the EU. By implementing them, Member States have the potential to organise their health systems more effectively, including the diagnosis and management of cancers detected in screening. There is good evidence that population-based screening using the EU-recommended test reduces mortality from colorectal cancer by around 15% in people of appropriate age (50 to 74 years) invited to attend screening.

    The guidelines, coordinated for the Commission by the International Agency for Research on Cancer (IARC), were developed with the input of over 90 experts from 32 countries, and set a benchmark for best practice in colorectal cancer screening. Widespread application of the Guidelines should also make it easier for experts in the field to exchange information and experience across the EU. This is essential for innovation and continuous quality improvement of existing cancer screening programmes.

    • Date de parution:
    • Editeur: Publications Office of the European Union
  • Dernière modification le 12-10-2015